ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
by Kiladjianm, Jean-Jacques (Author)
, Marin, Francisca Ferrer (Author)
, Al-Ali, Haifa Kathrin (Author)
, Alvarez-Larrán, Alberto (Author)
, Beggiato, Eloise (Author)
, Bieniaszewska, Maria (Author)
, Breccia, Massimo (Author)
, Buxhofer-Ausch, Veronika (Author)
, Cerna, Olga (Author)
, Crisan, Ana-Manuela (Author)
, Reiter, Andreas (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource